ESMO 2026 INTELLIGENCE · MADRIDKnow what top breast cancer KOLs think about your drug — before, during and after ESMO. Six seats only.Request the brochure →
GRG Health Talk to our team
← Back to insights
Whitepapers · GRG Health · 13 December 2023

Understanding the Major Depressive Disorder (MDD) Landscape in Singapore

Format
Whitepaper
Therapy area
Neurology & Mental Health
Published
Q4 2023
Access
On request · sent by email
What's in the report

Inside the report

  1. 01 The patient journeyfrom first symptoms to diagnosis and treatment in Singapore's system
  2. 02 Treatment pathwayshow psychiatrists and primary care manage MDD, and where they refer
  3. 03 Market picturethe treatment classes in use and how they are chosen
  4. 04 Access and stigmathe barriers patients face in seeking and staying in care
  5. 05 Clinical needswhat treaters say is missing from current options
  6. 06 Recommendationsfor manufacturers, providers and the health system
Executive summary

What this report tells you

Major depressive disorder in Singapore is shaped by a distinctive mix of health system, culture and access. This report maps the MDD landscape there: the patient journey, the treatment pathways clinicians follow, and the market that results.

It draws on treating clinicians to describe how patients reach care, how they are managed, what stands in the way, and where the unmet needs lie, and closes with recommendations for the organisations serving this market.

The full report is available on request. Leave your details below and our team will email it to you.

HCP Market Pulse · full report

Request the full report.

The complete report — full sample, methodology and every cut — is available on request. Leave your work details and our team will email it to you.

← Back to the report library